Learn more

CANTABRIA IND FARMACEUTICA SA

Overview
  • Total Patents
    35
  • GoodIP Patent Rank
    200,729
  • Filing trend
    ⇩ 100.0%
About

CANTABRIA IND FARMACEUTICA SA has a total of 35 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1967. It filed its patents most often in EPO (European Patent Office), Spain and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are WU CHENGBIN, ZAKRYTOE AKTSIONERNOE OBSCHESTVO PHARM SINTEZ and ONTOCHEM GMBH.

Patent filings per year

Chart showing CANTABRIA IND FARMACEUTICA SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Pivel Ranieri Juan Pablo 16
#2 Guerrero Gomez-Pamo Antonio 10
#3 Brieva Delgado Aurora 9
#4 Dominguez Valdes-Hevia Marta 7
#5 Pathak Madhukar A 7
#6 Fitzpatrick Thomas B 5
#7 Matji Tuduri Jose Antonio 5
#8 Gimenez Gallego Guillermo 5
#9 Garcia Martinez Fernando 4
#10 Gonzalez Rodriguez Salvador 4

Latest patents

Publication Filing date Title
EP3260170A1 Use of extracts of deschampsia antarctica for counteracting human skin barrier damage caused by environmental aggressions
WO2011092350A1 Product for the preparation of dermatological, cosmetic or cosmeceutical compositions intended for skin treatment
WO2005094773A1 Photoprotective and/or photoimmunoprotective compositions for the skin and uses thereof
US2004142414A1 Production of heterologous protein in a minimal culture medium
ES2299280A1 Mixed hydrophilic gels as controlled release vehicles or floating dispersants
ES2163966A1 Glicoconjugados constituted by the non-covalent association of polisacarids with polypeptides.
ES2105972A1 A procedure for the obtaining of biological response modifiers with recovery activity of the hematopoyetic function from, equally and indistincately, two bacterial strains fixing n2 azotobacter chroococcum and vinel azotobacter.
ES2112765A1 Procedure for obtaining radiological contrast formulations, for gastrointestinal explorations for extemporary and direct use.
US5614197A Polypodium extract as photoprotectant
ES2068154A1 New analgesic formulations with wide interval of action.
ES347889A1 A procedure for the preparation of a compound derived from tetracycline. (Machine-translation by Google Translate, not legally binding)